19-10111519-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020230.7(PPAN):​c.*354A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.583 in 661,124 control chromosomes in the GnomAD database, including 113,936 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).

Frequency

Genomes: 𝑓 0.56 ( 24108 hom., cov: 32)
Exomes 𝑓: 0.59 ( 89828 hom. )

Consequence

PPAN
NM_020230.7 3_prime_UTR

Scores

2

Clinical Significance

association no assertion criteria provided O:1

Conservation

PhyloP100: -0.269

Publications

24 publications found
Variant links:
Genes affected
PPAN (HGNC:9227): (peter pan homolog) The protein encoded by this gene is an evolutionarily conserved protein similar to yeast SSF1 as well as to the gene product of the Drosophila gene peter pan (ppan). SSF1 is known to be involved in the second step of mRNA splicing. Both SSF1 and ppan are essential for cell growth and proliferation. Exogenous expression of this gene was reported to reduce the anchorage-independent growth of some tumor cells. Read-through transcription of this gene with P2RY11/P2Y(11), an adjacent downstream gene that encodes an ATP receptor, has been found. These read-through transcripts are ubiquitously present and up-regulated during granulocyte differentiation. [provided by RefSeq, Nov 2010]
PPAN-P2RY11 (HGNC:33526): (PPAN-P2RY11 readthrough) This locus represents naturally occurring read-through transcription between the adjacent PPAN and P2RY11 genes. Alternative splicing results in two transcript variants, one of which encodes a fusion protein that shares sequence identity with each individual gene product. This transcript is found to be ubiquitously expressed and is up-regulated by agents inducing granulocytic differentiation. However, its functional significance in vivo remains unclear. [provided by RefSeq, Nov 2010]
P2RY11 (HGNC:8540): (purinergic receptor P2Y11) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is coupled to the stimulation of the phosphoinositide and adenylyl cyclase pathways and behaves as a selective purinoceptor. Naturally occuring read-through transcripts, resulting from intergenic splicing between this gene and an immediately upstream gene (PPAN, encoding peter pan homolog), have been found. The PPAN-P2RY11 read-through mRNA is ubiquitously expressed and encodes a fusion protein that shares identity with each individual gene product. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.706 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020230.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPAN
NM_020230.7
MANE Select
c.*354A>G
3_prime_UTR
Exon 12 of 12NP_064615.3
PPAN
NM_001346139.1
c.*354A>G
3_prime_UTR
Exon 12 of 12NP_001333068.1
PPAN
NM_001346141.1
c.*354A>G
3_prime_UTR
Exon 11 of 11NP_001333070.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPAN
ENST00000253107.12
TSL:1 MANE Select
c.*354A>G
3_prime_UTR
Exon 12 of 12ENSP00000253107.7
PPAN-P2RY11
ENST00000393796.4
TSL:1
c.1279+497A>G
intron
N/AENSP00000377385.4
PPAN
ENST00000486482.1
TSL:2
n.902A>G
non_coding_transcript_exon
Exon 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.557
AC:
84557
AN:
151814
Hom.:
24089
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.470
Gnomad AMI
AF:
0.519
Gnomad AMR
AF:
0.638
Gnomad ASJ
AF:
0.555
Gnomad EAS
AF:
0.725
Gnomad SAS
AF:
0.694
Gnomad FIN
AF:
0.604
Gnomad MID
AF:
0.494
Gnomad NFE
AF:
0.562
Gnomad OTH
AF:
0.594
GnomAD4 exome
AF:
0.590
AC:
300603
AN:
509190
Hom.:
89828
Cov.:
6
AF XY:
0.596
AC XY:
159530
AN XY:
267886
show subpopulations
African (AFR)
AF:
0.471
AC:
6652
AN:
14130
American (AMR)
AF:
0.679
AC:
16159
AN:
23782
Ashkenazi Jewish (ASJ)
AF:
0.549
AC:
8188
AN:
14914
East Asian (EAS)
AF:
0.717
AC:
22565
AN:
31488
South Asian (SAS)
AF:
0.680
AC:
33988
AN:
49968
European-Finnish (FIN)
AF:
0.593
AC:
18243
AN:
30746
Middle Eastern (MID)
AF:
0.526
AC:
1126
AN:
2140
European-Non Finnish (NFE)
AF:
0.565
AC:
177389
AN:
313826
Other (OTH)
AF:
0.578
AC:
16293
AN:
28196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
6295
12590
18884
25179
31474
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1558
3116
4674
6232
7790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.557
AC:
84619
AN:
151934
Hom.:
24108
Cov.:
32
AF XY:
0.563
AC XY:
41809
AN XY:
74256
show subpopulations
African (AFR)
AF:
0.470
AC:
19476
AN:
41432
American (AMR)
AF:
0.637
AC:
9724
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.555
AC:
1925
AN:
3468
East Asian (EAS)
AF:
0.726
AC:
3724
AN:
5132
South Asian (SAS)
AF:
0.694
AC:
3349
AN:
4824
European-Finnish (FIN)
AF:
0.604
AC:
6373
AN:
10552
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.562
AC:
38171
AN:
67954
Other (OTH)
AF:
0.596
AC:
1259
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1914
3829
5743
7658
9572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.564
Hom.:
31529
Bravo
AF:
0.559
Asia WGS
AF:
0.688
AC:
2391
AN:
3478

ClinVar

Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Cataplexy and narcolepsy Other:1
Dec 10, 2014
Center for Narcolepsy, Stanford University
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.6
DANN
Benign
0.38
PhyloP100
-0.27
PromoterAI
0.072
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12460842; hg19: chr19-10222195; COSMIC: COSV53452551; COSMIC: COSV53452551; API